Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc.
Case Number:
1:20-cv-00110
Court:
Nature of Suit:
835(Patent - Abbreviated New Drug Applications (ANDA))
Judge:
District Judge John Preston Bailey
Firms
Companies
Sectors & Industries:
-
February 15, 2024
IP Forecast: 'No Labels' Party Feuds With Website Over Name
In advance of debuting candidates for its promised "Unity Ticket for 2024," third-party political group No Labels will fight next week with a website's owners who say the group's name is merely a generic phrase any candidate can use. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
June 07, 2022
Mylan Takes Actelion Drug IP Fight To Fed. Circ.
Mylan Pharmaceuticals Inc. said Tuesday it's appealing to the Federal Circuit a West Virginia district judge's claim construction order after being blocked from selling a generic version of rival Actelion Pharmaceuticals Ltd.'s blood pressure treatment Veletri.